Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "congenital sucrase-isomaltase deficiency"
Show Display Options
Rank Status Study
1 Unknown  Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
Condition: Congenital Sucrase-isomaltase Deficiency (CSID)
Intervention:
2 Active, not recruiting A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency
Condition: Genetic Sucrase-Isomaltase Deficiency
Interventions: Drug: Sucraid;   Drug: Placebo

Indicates status has not been verified in more than two years